Xylazine is a sedative and pain-relieving drug used in veterinary medicine, primarily in horses, dogs, and cats. It’s FDA-approved for these three species and has been a staple in veterinary clinics for over 50 years, valued for its reliable ability to calm animals, reduce pain during procedures, and serve as a stepping stone to deeper anesthesia when surgery is needed.
How Xylazine Works
Xylazine belongs to a class of drugs that mimic the action of norepinephrine, one of the body’s stress-signaling chemicals, on specific receptors in the nervous system. By activating these receptors, it essentially tricks the brain into dialing down its own alert signals. The result is a dose-dependent sedation: lower amounts produce calm and mild pain relief, while higher amounts can push an animal into a deep, sleep-like state.
After an intramuscular injection, xylazine typically takes effect within 10 to 15 minutes. The sedation generally lasts 1 to 2 hours depending on the dose, though pain relief is shorter, usually fading after 15 to 30 minutes. Increasing the dose deepens the sedation and extends its duration, giving veterinarians flexibility in matching the drug to the procedure.
Uses in Horses
Horses are the species most commonly associated with xylazine. The drug’s FDA-approved label for horses covers an extensive list of applications, from routine diagnostic work to surgical preparation. Veterinarians use it during oral and eye exams, abdominal and rectal palpation, vaginal examinations, bladder catheterization, and radiographic imaging. For orthopedic work, it keeps a horse still enough to apply casts or splints.
Xylazine also plays a role in dental procedures and minor surgeries like wound cleaning, removal of skin growths, and suturing lacerations. For major surgery, it serves as a preanesthetic, smoothing the transition into general anesthesia and reducing the amount of other anesthetic drugs needed. It can also be paired with local anesthetics for more targeted procedures. Beyond clinical settings, it’s simply used to calm fractious horses that are difficult to handle safely.
Uses in Dogs
In dogs, xylazine produces reliable sedation at intramuscular doses of 1 to 3 mg per kilogram of body weight, ranging from moderate calm to deep hypnosis at the higher end. Its most common role in canine medicine is as a premedicant before anesthesia. Even when the sedation itself isn’t dramatic, xylazine significantly reduces the amount of induction agent needed to put a dog fully under, making the overall anesthetic process smoother and safer.
One notable side effect in dogs is vomiting, which commonly occurs as sedation sets in. This might sound like a drawback, but it’s sometimes considered a useful feature in emergency situations where a dog has swallowed something toxic. That said, xylazine does not produce reliable, consistent vomiting in dogs, so it’s not a first-choice option for that purpose. As an ongoing pain management tool, xylazine has largely fallen out of favor in small animal practice, replaced by newer drugs with fewer cardiovascular side effects.
Uses in Cats
Cats respond well to xylazine’s sedative properties, and the drug has a specific additional use in feline medicine: inducing vomiting after poisoning or ingestion of foreign material. At a slightly lower dose than what’s used for sedation (around 0.44 mg/kg), xylazine triggers vomiting in cats, typically within 10 minutes. This makes it a practical tool in feline emergency care, though its effectiveness isn’t guaranteed in every case.
Xylazine is also used in large-scale spay and neuter programs for free-roaming cats. In these settings, it’s combined with other anesthetic agents like ketamine and tiletamine-zolazepam in a single intramuscular injection. This cocktail provides the three pillars of surgical anesthesia: unconsciousness, pain control, and muscle relaxation, all delivered without needing to place an IV catheter first, which is essential when working with feral animals that can’t be easily handled.
Ruminants and Other Species
Cattle, sheep, goats, and deer are far more sensitive to xylazine than horses, dogs, or cats. These ruminant species require roughly one-tenth the dose used in horses to achieve the same level of sedation. This extreme sensitivity means that doses considered routine in other animals can cause dangerous complications in ruminants, including significant drops in blood oxygen levels. Goats and sheep are particularly prone to this oxygen-related side effect.
The FDA-approved label for one xylazine formulation specifically includes cervidae (the deer family) alongside horses. In wildlife management and zoo medicine, xylazine is used for chemical immobilization of deer and elk during capture, tagging, relocation, and veterinary examination.
Cardiovascular Side Effects
Xylazine’s most clinically significant side effects involve the heart and circulatory system. In dogs, intravenous administration causes a measurable drop in heart rate, decreased blood flow from the heart, and an initial spike in blood pressure followed by a sustained drop. Peripheral blood vessels constrict, increasing resistance to blood flow. These effects also occur with intramuscular injection, though the blood pressure changes are less pronounced.
Breathing is less affected. Studies in dogs show that standard doses don’t significantly change blood oxygen levels, carbon dioxide levels, or blood pH, meaning the lungs continue functioning normally even as the cardiovascular system slows. Still, the combination of slow heart rate, low blood pressure, and poor tissue perfusion makes xylazine a concern in animals that are already cardiovascularly compromised.
Reversal With Antagonist Drugs
One of xylazine’s practical advantages is that its effects can be chemically reversed. Three antagonist drugs are used in veterinary practice, each working by blocking the same receptors xylazine activates. Tolazoline is FDA-approved specifically for reversing xylazine, particularly in large animals and deer. Yohimbine is another option used across species. Atipamezole, the most potent of the three, produces the fastest recovery times.
In a controlled study comparing reversal agents in mice anesthetized with a ketamine-xylazine combination, atipamezole restored normal function in an average of about 10 minutes, compared to 21 minutes for yohimbine and 38 minutes for saline alone. Veterinarians do exercise some caution with reversal speed, though. Very rapid, complete reversal can trigger excitement or agitation, so lower doses of the antagonist are sometimes preferred to allow a gentler wake-up.
Regulatory Status
Xylazine is not a controlled substance under federal law. It’s regulated as a veterinary drug through the FDA but is not scheduled by the Drug Enforcement Administration, which means it doesn’t carry the same purchasing, storage, and record-keeping requirements as drugs like ketamine. This distinction has come under scrutiny in recent years due to xylazine’s appearance in the illicit drug supply, and Congress has considered whether placing it in Schedule II would be appropriate. Such a change would add handling restrictions for veterinary professionals while preserving its availability for legitimate animal care.